Matches in SemOpenAlex for { <https://semopenalex.org/work/W2041683146> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2041683146 abstract "Background: The last focused update of the ESC guidelines for the management of atrial fibrillation (AF) recommended to use antithrombotic therapy for the prevention of thromboembolic events for all patients with AF except in those at low risk. Nevertheless, little is known about the impact of these recommendations in clinical practice of different European countries.Methods: The PREvention oF thromboembolic events – European Registry in Atrial Fibrillation (PREFER in AF) recruited unselected patients in Austria, France, Germany, Italy, Spain, Switzerland and the United Kingdom from Jan 2012 to Jan 2013. We report the data collected at enrolment into the study.Results: 7243 consecutive patients were enrolled. 5856 of them had a transthoracic echocardiography performed in the 12 months period prior to inclusion. While the overall prevalence of patients with CHA2DS2-VASc of 0 was very low, there were 1282 (17.7%) patients who did not receive antithrombotic therapy, including 808 patients (11.2%) who received antiplatelet (AP) therapy and 474 patients (6.5%) who had no preventive treatment at all. Patients who received AP or no preventive treatment had a lower prevalence of left atrial dilation than the overall population of the study (59.0% and 48.3% respectively vs. 70.1%, p<0.01) and were more frequently affected by paroxysmal AF (51.4% for AP group and 51.0% for no treatment vs. 30% overall, p<0.01). Those with no antithrombotic treatment tended to be younger than the average (67.4±14.3 years vs. 71.5±10.7 years, p<0.01), but no differences were seen for the AP group (70.9±11.8 years, p=0.11).Conclusions: There is still a significant proportion of patients with AF who, despite a raised risk of thromboembolism, do not receive appropriate treatment in Europe. Parameters associated with under-treatment suggest that this occurs more often in patients in initial stages of AF, despite the guideline recommendation of antithrombotic treatment only according to the risk profile." @default.
- W2041683146 created "2016-06-24" @default.
- W2041683146 creator A5038009607 @default.
- W2041683146 creator A5047325459 @default.
- W2041683146 creator A5048095806 @default.
- W2041683146 creator A5058395111 @default.
- W2041683146 creator A5067302152 @default.
- W2041683146 creator A5069145859 @default.
- W2041683146 creator A5073886328 @default.
- W2041683146 creator A5087186735 @default.
- W2041683146 creator A5091063706 @default.
- W2041683146 date "2013-08-02" @default.
- W2041683146 modified "2023-09-26" @default.
- W2041683146 title "Patterns of anticoagulant underuse in European AF patients in 2012 - results from PREFER in AF registry" @default.
- W2041683146 doi "https://doi.org/10.1093/eurheartj/eht308.1075" @default.
- W2041683146 hasPublicationYear "2013" @default.
- W2041683146 type Work @default.
- W2041683146 sameAs 2041683146 @default.
- W2041683146 citedByCount "0" @default.
- W2041683146 crossrefType "journal-article" @default.
- W2041683146 hasAuthorship W2041683146A5038009607 @default.
- W2041683146 hasAuthorship W2041683146A5047325459 @default.
- W2041683146 hasAuthorship W2041683146A5048095806 @default.
- W2041683146 hasAuthorship W2041683146A5058395111 @default.
- W2041683146 hasAuthorship W2041683146A5067302152 @default.
- W2041683146 hasAuthorship W2041683146A5069145859 @default.
- W2041683146 hasAuthorship W2041683146A5073886328 @default.
- W2041683146 hasAuthorship W2041683146A5087186735 @default.
- W2041683146 hasAuthorship W2041683146A5091063706 @default.
- W2041683146 hasBestOaLocation W20416831461 @default.
- W2041683146 hasConcept C126322002 @default.
- W2041683146 hasConcept C187212893 @default.
- W2041683146 hasConcept C2777015399 @default.
- W2041683146 hasConcept C2779161974 @default.
- W2041683146 hasConcept C2908647359 @default.
- W2041683146 hasConcept C2993316766 @default.
- W2041683146 hasConcept C71924100 @default.
- W2041683146 hasConcept C99454951 @default.
- W2041683146 hasConceptScore W2041683146C126322002 @default.
- W2041683146 hasConceptScore W2041683146C187212893 @default.
- W2041683146 hasConceptScore W2041683146C2777015399 @default.
- W2041683146 hasConceptScore W2041683146C2779161974 @default.
- W2041683146 hasConceptScore W2041683146C2908647359 @default.
- W2041683146 hasConceptScore W2041683146C2993316766 @default.
- W2041683146 hasConceptScore W2041683146C71924100 @default.
- W2041683146 hasConceptScore W2041683146C99454951 @default.
- W2041683146 hasLocation W20416831461 @default.
- W2041683146 hasOpenAccess W2041683146 @default.
- W2041683146 hasPrimaryLocation W20416831461 @default.
- W2041683146 hasRelatedWork W1503548792 @default.
- W2041683146 hasRelatedWork W1942434162 @default.
- W2041683146 hasRelatedWork W2004305925 @default.
- W2041683146 hasRelatedWork W2050400527 @default.
- W2041683146 hasRelatedWork W2052227976 @default.
- W2041683146 hasRelatedWork W2170845996 @default.
- W2041683146 hasRelatedWork W2276030981 @default.
- W2041683146 hasRelatedWork W2388498632 @default.
- W2041683146 hasRelatedWork W2439066858 @default.
- W2041683146 hasRelatedWork W2469651094 @default.
- W2041683146 hasRelatedWork W2614653076 @default.
- W2041683146 hasRelatedWork W2620982785 @default.
- W2041683146 hasRelatedWork W2626060092 @default.
- W2041683146 hasRelatedWork W2626979474 @default.
- W2041683146 hasRelatedWork W2766350603 @default.
- W2041683146 hasRelatedWork W2782336735 @default.
- W2041683146 hasRelatedWork W2879889508 @default.
- W2041683146 hasRelatedWork W3000545894 @default.
- W2041683146 hasRelatedWork W3003141915 @default.
- W2041683146 hasRelatedWork W3118638769 @default.
- W2041683146 isParatext "false" @default.
- W2041683146 isRetracted "false" @default.
- W2041683146 magId "2041683146" @default.
- W2041683146 workType "article" @default.